Purpose: Although walking is the most commonly recommended activity for patients with type 2 diabetes (T2D), these patients walk daily less than their healthy peers and adopt a lower self-selected speed. It has been suggested that gait alterations observed in this population could be responsible for a higher metabolic rate (MR) during walking. Thus, the aim of this study was to compare relationship between MR, the energy cost of walking per unit of distance (Cw) and self-selected walking speed in T2D patients and healthy individuals.
Methods: We measured metabolic and spatiotemporal parameters for 20 T2D patients and 20 healthy control subjects, while they walked on a treadmill at different speeds (0.50-1.75 m s) using a breath-by-breath gas analyzer and an inertial measurement unit, respectively.
Results: Net MR was 14.3% higher for T2D patients on average across all speeds, and they preferred to walk 6.8% slower at their self-selected compared with their non-diabetics counterparts (1.33 vs. 1.42 m s, respectively; p = 0.045). Both groups naturally walked at a self-selected speed close to their minimum gross Cw per distance, with similar values of minimum gross Cw (3.53 and 3.32 J kg m in T2D patients and control subjects, respectively).
Conclusion: When compared with healthy subjects, T2D patients walk with a higher MR at any given speed. Thus, the slower self-selected speed observed in T2D patients seems to correspond to the speed at which their gross energy cost per distance was minimized and allows T2D patients to walk at the same intensity than healthy subjects.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00421-018-3959-z | DOI Listing |
Diabetes Ther
December 2024
Patient Author, Heart Sistas, North Lauderdale, FL, USA.
Type 2 diabetes (T2D) frequently coexists with cardiorenal complications. Therefore, a holistic approach to patient management is required, with specialists such as primary care physicians, cardiologists, endocrinologists, and nephrologists working together to provide patient care. Although glycemic control is important in the management of T2D, patients with T2D and acceptable glycemic control are still at risk from cardiovascular (CV) events such as stroke, heart attack, and heart failure (HF).
View Article and Find Full Text PDFCancer Epidemiol
December 2024
Steno Diabetes Center Aarhus, Aarhus, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark. Electronic address:
Background: Cancer has become the leading cause of death among individuals with type 2 diabetes (T2D) in high-income countries. T2D is suggested to directly influence cancer progression. However, the association between T2D and melanoma stage at diagnosis remains uncertain, as well as any potential sex disparities.
View Article and Find Full Text PDFDiabetes Obes Metab
December 2024
Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa, Japan.
Aims: This study aimed to evaluate the effectiveness of imeglimin in improving liver function and fibrosis in patients with type 2 diabetes (T2D) complicated by metabolic dysfunction-associated steatotic liver disease (MASLD).
Materials And Methods: We conducted a multicentre study involving 80 patients with T2D and MASLD who were treated with or without imeglimin for 24 weeks. We assessed the changes in diabetes-related parameters, including HbA1c, fasting blood glucose, glycoalbumin and C-peptide index.
J Am Board Fam Med
December 2024
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
Background: The association between interpersonal continuity of care (CoC) and progression from the prediabetic state to Type 2 Diabetes (T2D) remains unknown.
Aim: To evaluate the association between interpersonal CoC and the progression to T2D among persons with prediabetes.
Design And Setting: A retrospective cohort study using electronic health record (EHR) data from 6620 patients at Geisinger, a large rural health care system in Danville, PA.
Front Endocrinol (Lausanne)
December 2024
Department of Endocrinology, Bogomolets National Medical University, Kyiv, Ukraine.
Introduction: Post-COVID-19 syndrome (PCS) is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated chronic condition characterized by long-term violations of physical and mental health. People with type 2 diabetes (T2D) are at high risk for severe COVID-19 and PCS.
Aim: The current study aimed to define the predictors of PCS development in people with T2D for further planning of preventive measures and improving patient outcomes.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!